Beam Therapeutics (BEAM) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

BMO Capital Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $57
Moomoo News12:31 ET · Ratings
Beam Therapeutics Analyst Ratings
Benzinga11:40 ET · Ratings
A Quick Look at Today's Ratings for Beam Therapeutics(BEAM.US), With a Forecast Between $31 to $57
Moomoo NewsFeb 26 08:00 ET · Ratings
RBC Raises Price Target on Beam Therapeutics to $26 From $24, Keeps Sector Perform, Speculative Risk
MT NewswiresFeb 26 06:56 ET · Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS) and Beam Therapeutics (BEAM)
TipRanksFeb 26 05:20 ET · Ratings
Express News | Beam Therapeutics Inc : Jefferies Raises Target Price to $30 From $23
ReutersFeb 26 02:01 ET

Comments

Moomoo News Global

Feb 21 06:16

Columns HIMS Jumps 174% YTD — Who's Next?

$Hims & Hers Health (HIMS.US)$ , an online health and wellness platform, has seen its stock soar over 78% since February, with a year-to-date surge exceeding 174%. This outpaces the projected full-year gain of 171% for 2024.
What's Fueling HIMS' Rally?
HIMS surged 17.5% on Wednesday following the announcement of an acquisition, reaching an intraday high of nearly 25% and hitting a record $72.
Hims & Hers disclosed it acquired Sigmund NJ LLC, also known as Trybe La...

30

2

43

Analysts Notebook

Feb 13 05:50

Columns Interest in AI-Powered MedTech is on the Rise: Key Stocks to Watch

The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...

113

13

278

Moomoo News Global

Feb 6 03:43

Columns AI Healthcare-tech May Be the Next Big Thing. Here's Why

US Congress member Nancy Pelosi and Ark Invest's Cathie Wood both bet big on an AI stock recently.
The stock in question is $Tempus AI (TEM.US)$, a company that uses data and artificial intelligence (AI) to create precision medicine services. ARK Invest, a prominent advocate for innovative technologies, first showed interest on December 6, when it purchased shares in this healthcare technology firm. Since that initial investment, Tempus AI h...

45

7

154

This_Guy

Dec 8, 2024 17:16

$Beam Therapeutics (BEAM.US)$
Beam Therapeutics Presents New Non-human Primate (NHP) Data Demonstrating Proof-of-concept for ESCAPE, a Non-genotoxic, Antibody-based Conditioning Approach to Treating Sickle Cell Disease, at American Society of Hematology (ASH) Annual Meeting
Beam Therapeutics (NASDAQ: BEAM) presented new data for its ESCAPE conditioning platform at the ASH Annual Meeting. The data demonstrated successful proof-of-concept in non-human primates (NHPs) for a non-genotoxic conditionin...

1

Moomoo News Global

Sep 10, 2024 08:28

Columns Here's What the Harris-Trump Debate Means for US Stocks

As the U.S. presidential election approaches in just two months, focus intensifies on the crucial debate between Vice President Kamala Harris and former President Donald Trump, scheduled for 9 p.m. ET on Tuesday, September 10. For investors strategizing around the "Trump trade" or the "Harris trade," the market's forward-looking reaction to their governing policies is critical. The election outcome will shape expectations of their administra...

+1

Trump trade: Bitcoin hit record highs and Tesla hits $1 trillion market cap

45

11

38

BEAM Beam Therapeutics

Trade Overview

Capital Trend

News

Comments

Trending Stocks